TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
ENGN

enGene Holdings Inc.

Healthcare · Biotechnology

2.00$ -0.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ENGN
Line item 2020 2021 2022 2023 2024 2025
– – +0.5% -34.1% +257.8% -28.8%
– – -67.4% +16,593.9% +189.5% -18.6%
– – -70.6% +25,849.6% +112.2% -71.0%
– – -70.6% +25,873.8% +192.2% -18.7%
– – -17.6% +75.4% -56.0% +115.8%
– – -8.6% +2.7% – –
– – +14.0% +213.2% +166.4% +39.4%
– – +172.9% +488.4% +178.9% +118.1%
– – +20.7% -55.6% +99.6% +792.7%
– – -27.8% +59.9% +22.1% +374.0%
– – +912.3% -70.1% +143.8% -31.8%
– – +0.0% -43.1% +276.1% -38.5%
– – – – – –
– +0.0% +0.0% +49.0% +89.5% +14.5%

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?